As WHO experts meet on Monday to evaluate the AstraZeneca jab's effects on the elderly, which is still facing doubts, South Africa has halted the launch of its inoculation program for million shots due to fears that the vaccine might not perform on the new variant in the response of the results from the trial conducted by the University of Witatersrand in Johannesburg, AFP reported.
